☰

Greg Hockerman - Publications

Affiliations: 
Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Area:
Physiology Biology, Cell Biology
Tree Info Similar researchers PubMed Report error

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Wang Y, Tang S, Harvey KE, Salyer AE, Li TA, Rantz EK, Lill MA, Hockerman GH. Molecular determinants of the differential modulation of Cav1.2 and Cav1.3 by nifedipine and FPL 64176. Molecular Pharmacology. PMID 29980657 DOI: 10.1124/Mol.118.112441  0.35
2017 Sealover NR, Felts B, Kuntz CP, Jarrard RE, Hockerman GH, Lamb PW, Barker EL, Henry LK. Corrigendum to "The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux" [Biochem. Pharmacol. 120 (2016) 46-55]. Biochemical Pharmacology. 147: 9. PMID 29195124 DOI: 10.1016/J.Bcp.2017.11.001  0.729
2016 Sealover NR, Felts B, Kuntz CP, Jarrard RE, Hockerman GH, Barker EL, Keith Henry L. The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux. Biochemical Pharmacology. PMID 27638414 DOI: 10.1016/J.Bcp.2016.09.006  0.734
2016 Pratt EP, Salyer AE, Guerra ML, Hockerman GH. Ca(2+) influx through L-type Ca(2+) channels and Ca(2+)-induced Ca(2+) release regulate cAMP accumulation and Epac1-dependent ERK 1/2 activation in INS-1 cells. Molecular and Cellular Endocrinology. 419: 60-71. PMID 26435461 DOI: 10.1016/J.Mce.2015.09.034  0.798
2014 Wang Y, Jarrard RE, Pratt EP, Guerra ML, Salyer AE, Lange AM, Soderling IM, Hockerman GH. Uncoupling of Cav1.2 from Ca(2+)-induced Ca(2+) release and SK channel regulation in pancreatic β-cells. Molecular Endocrinology (Baltimore, Md.). 28: 458-76. PMID 24506535 DOI: 10.1210/Me.2013-1094  0.788
2013 Han C, Salyer AE, Kim EH, Jiang X, Jarrard RE, Powers MS, Kirchhoff AM, Salvador TK, Chester JA, Hockerman GH, Colby DA. Evaluation of difluoromethyl ketones as agonists of the γ-aminobutyric acid type B (GABAB) receptor. Journal of Medicinal Chemistry. 56: 2456-65. PMID 23428109 DOI: 10.1021/Jm301805E  0.72
2013 Jarrard RE, Wang Y, Salyer AE, Pratt EP, Soderling IM, Guerra ML, Lange AM, Broderick HJ, Hockerman GH. Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influx. Molecular Pharmacology. 83: 191-205. PMID 23071106 DOI: 10.1124/Mol.112.081943  0.78
2011 Lin M, Aladejebi O, Hockerman GH. Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive. European Journal of Pharmacology. 670: 105-13. PMID 21910984 DOI: 10.1016/J.Ejphar.2011.08.005  0.515
2011 Shabbir W, Beyl S, Timin EN, Schellmann D, Erker T, Hohaus A, Hockerman GH, Hering S. Interaction of diltiazem with an intracellularly accessible binding site on Ca(V)1.2. British Journal of Pharmacology. 162: 1074-82. PMID 20973779 DOI: 10.1111/j.1476-5381.2010.01091.x  0.391
2009 Jacobo SM, Guerra ML, Hockerman GH. Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1. The Journal of Pharmacology and Experimental Therapeutics. 331: 724-32. PMID 19710366 DOI: 10.1124/Jpet.109.158519  0.823
2009 Jacobo SM, Guerra ML, Jarrard RE, Przybyla JA, Liu G, Watts VJ, Hockerman GH. The intracellular II-III loops of Cav1.2 and Cav1.3 uncouple L-type voltage-gated Ca2+ channels from glucagon-like peptide-1 potentiation of insulin secretion in INS-1 cells via displacement from lipid rafts. The Journal of Pharmacology and Experimental Therapeutics. 330: 283-93. PMID 19351867 DOI: 10.1124/Jpet.109.150672  0.74
2007 Walsh KB, Zhang J, Fuseler JW, Hilliard N, Hockerman GH. Adenoviral-mediated expression of dihydropyridine-insensitive L-type calcium channels in cardiac ventricular myocytes and fibroblasts. European Journal of Pharmacology. 565: 7-16. PMID 17397827 DOI: 10.1016/J.Ejphar.2007.02.049  0.441
2006 Vikman J, Ma X, Hockerman GH, Rorsman P, Eliasson L. Antibody inhibition of synaptosomal protein of 25 kDa (SNAP-25) and syntaxin 1 reduces rapid exocytosis in insulin-secreting cells. Journal of Molecular Endocrinology. 36: 503-15. PMID 16720719 DOI: 10.1677/Jme.1.01978  0.326
2006 Liu G, Jacobo SM, Hilliard N, Hockerman GH. Differential modulation of Cav1.2 and Cav1.3-mediated glucose-stimulated insulin secretion by cAMP in INS-1 cells: distinct roles for exchange protein directly activated by cAMP 2 (Epac2) and protein kinase A. The Journal of Pharmacology and Experimental Therapeutics. 318: 152-60. PMID 16565168 DOI: 10.1124/Jpet.105.097477  0.788
2004 Spelbrink RG, Dilmac N, Allen A, Smith TJ, Shah DM, Hockerman GH. Differential antifungal and calcium channel-blocking activity among structurally related plant defensins. Plant Physiology. 135: 2055-67. PMID 15299136 DOI: 10.1104/Pp.104.040873  0.783
2004 Dilmac N, Hilliard N, Hockerman GH. Molecular determinants of frequency dependence and Ca2+ potentiation of verapamil block in the pore region of Cav1.2. Molecular Pharmacology. 66: 1236-47. PMID 15286207 DOI: 10.1124/Mol.104.000893  0.821
2004 Liu G, Hilliard N, Hockerman GH. Cav1.3 is preferentially coupled to glucose-induced [Ca2+]i oscillations in the pancreatic beta cell line INS-1. Molecular Pharmacology. 65: 1269-77. PMID 15102955 DOI: 10.1124/Mol.65.5.1269  0.679
2003 Dilmac N, Hilliard N, Hockerman GH. Molecular determinants of Ca2+ potentiation of diltiazem block and Ca2+-dependent inactivation in the pore region of cav1.2. Molecular Pharmacology. 64: 491-501. PMID 12869655 DOI: 10.1124/Mol.64.2.491  0.825
2003 Liu G, Dilmac N, Hilliard N, Hockerman GH. Ca v 1.3 is preferentially coupled to glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1. The Journal of Pharmacology and Experimental Therapeutics. 305: 271-8. PMID 12649379 DOI: 10.1124/Jpet.102.046334  0.83
2000 Hockerman GH, Dilmac N, Scheuer T, Catterall WA. Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels. Molecular Pharmacology. 58: 1264-70. PMID 11093762 DOI: 10.1124/Mol.58.6.1264  0.794
1997 Hockerman GH, Peterson BZ, Sharp E, Tanada TN, Scheuer T, Catterall WA. Construction of a high-affinity receptor site for dihydropyridine agonists and antagonists by single amino acid substitutions in a non-L-type Ca2+ channel. Proceedings of the National Academy of Sciences of the United States of America. 94: 14906-11. PMID 9405712 DOI: 10.1073/pnas.94.26.14906  0.437
1997 Hockerman GH, Johnson BD, Abbott MR, Scheuer T, Catterall WA. Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels in transmembrane segment IIIS6 and the pore region of the alpha1 subunit. The Journal of Biological Chemistry. 272: 18759-65. PMID 9228049 DOI: 10.1074/jbc.272.30.18759  0.371
1997 Peterson BZ, Johnson BD, Hockerman GH, Acheson M, Scheuer T, Catterall WA. Analysis of the dihydropyridine receptor site of L-type calcium channels by alanine-scanning mutagenesis. The Journal of Biological Chemistry. 272: 18752-8. PMID 9228048 DOI: 10.1074/jbc.272.30.18752  0.481
1997 Hockerman GH, Peterson BZ, Johnson BD, Catterall WA. Molecular determinants of drug binding and action on L-type calcium channels. Annual Review of Pharmacology and Toxicology. 37: 361-96. PMID 9131258 DOI: 10.1146/annurev.pharmtox.37.1.361  0.338
1997 Herlitze S, Hockerman GH, Scheuer T, Catterall WA. Molecular determinants of inactivation and G protein modulation in the intracellular loop connecting domains I and II of the calcium channel alpha1A subunit. Proceedings of the National Academy of Sciences of the United States of America. 94: 1512-6. PMID 9037084 DOI: 10.1073/pnas.94.4.1512  0.364
1997 Johnson BD, Brousal JP, Peterson BZ, Gallombardo PA, Hockerman GH, Lai Y, Scheuer T, Catterall WA. Modulation of the cloned skeletal muscle L-type Ca2+ channel by anchored cAMP-dependent protein kinase. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1243-55. PMID 9006969 DOI: 10.1523/Jneurosci.17-04-01243.1997  0.44
1996 Johnson BD, Hockerman GH, Scheuer T, Catterall WA. Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines. Molecular Pharmacology. 50: 1388-400. PMID 8913371  0.307
1995 Hockerman GH, Johnson BD, Scheuer T, Catterall WA. Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels. The Journal of Biological Chemistry. 270: 22119-22. PMID 7673189 DOI: 10.1074/jbc.270.38.22119  0.41
Show low-probability matches.